Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal Osteoporosis

NCT06951776 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Circadian Rhythm Disorders
Osteoporosis

Interventions

BEHAVIORAL: Morning administration group of teriparatide
BEHAVIORAL: Evening administration group of teriparatide

Sponsor

Peking University Third Hospital